2011 Annual Meeting | Hot Topics Plenary Session

Date Tuesday 04/12/11

Time 05:15 PM - 06:15 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Plenary Session

Topic(s) Cerebrovascular Disease and Interventional Neurology

CME Available No CME available

Event Timeline
05:15 PM - 06:15 PM		Break
05:15 PM - 06:15 PM		NIH Childhood Absence Epilepsy Trial: Clinical Outcomes, Underlying Science and Lessons Learned Tracy A. Glauser, MD
05:15 PM - 06:15 PM		NIH and the Taxpayer's Investment in Neurological Research Walter J. Koroshetz, MD, FAAN
05:15 PM - 06:15 PM		The Pharmacogenomics of Clopidogrel Metabolism: Incorporating Emerging Science into Clinical Practice Karen L. Furie, MD

Faculty Disclosures
Karen L. Furie, MD	The institution of Dr. Furie has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen/BMS. Dr. Furie has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for BMJ/JNNP. The institution of Dr. Furie has received research support from NINDS.
Walter J. Koroshetz, MD, FAAN	Dr. Koroshetz has nothing to disclose.
Tracy A. Glauser, MD	Dr. Glauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurelis. Dr. Glauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for WebMD. The institution of Dr. Glauser has received research support from NIH. Dr. Glauser has received intellectual property interests from a discovery or technology relating to health care. Dr. Glauser has received publishing royalties from a publication relating to health care.

��ɫ����